The evarrest market research report is one of a series of new reports that provides evarrest market statistics, including evarrest industry global market size, regional shares, competitors with a evarrest market share, detailed evarrest market segments, market trends and opportunities, and any further data you may need to thrive in the evarrest industry. This evarrest market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising cases of oral cancer, increasing prevalence of cancer, increase in chronic conditions, and rising prevalence of chronic and autoimmune diseases. Major trends in the forecast period include advancements in biosimilar development, innovation in drug development, technological advancements in biomarkers and diagnostics, integration of digital technologies, and sustainability in biologics manufacturing.
The growth of the evarrest market is expected to be driven by the increasing number of surgical procedures. Surgical procedures involve medical operations performed by a surgeon to treat, diagnose, or prevent various conditions, injuries, or diseases. The rising number of surgeries is attributed to the aging population and advancements in medical technology, making surgeries safer and more accessible. Evarrest is utilized during surgical procedures by applying its fibrin sealant patch to bleeding sites, where it facilitates rapid clot formation to effectively control bleeding. For example, in December 2023, the UK Health Security Agency reported an increase in coronary artery bypass graft surgeries, with 27,524 surgeries performed in 2023, compared to previous years. As a result, the growing number of surgical procedures is fueling the growth of the evarrest market.
The increasing adoption of personalized medicine is expected to drive the future growth of the evarrest market. Personalized medicine involves treatments tailored to an individual’s genetic makeup, lifestyle, and specific health conditions, aiming to provide more effective and precise care. The rise of personalized medicine is attributed to its ability to offer targeted treatments with fewer side effects. In the case of evarrest, its use can be customized based on patient factors, such as genetic traits or clotting disorders, to enhance treatment efficacy and safety. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from the 6 treatments approved in 2022. Therefore, the growing adoption of personalized medicine is contributing to the expansion of the evarrest market.
The increasing healthcare expenditure is also expected to boost the growth of the evarrest market. Healthcare expenditure encompasses the total financial resources allocated to medical services, preventive care, medications, and health-related activities aimed at improving or maintaining population health. The growth in healthcare spending is driven by the needs of aging populations requiring more medical care and the rising costs of advanced technologies. This increased expenditure supports the adoption of evarrest by investing in medical technologies that improve surgical outcomes and reduce complications. For example, the Centers for Medicare & Medicaid Services reported that U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion, surpassing the 3.2% growth seen in 2021. As a result, rising healthcare expenditure is driving the growth of the evarrest market.
The countries covered in the evarrest market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Evarrest is an FDA-approved fibrin sealant patch designed to control bleeding during surgical procedures. It consists of a flexible composite patch coated with human fibrinogen and thrombin, which allows for rapid clot formation. This product is particularly valuable in emergency situations, as it requires no preparation and effectively stops bleeding on the first application.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for evarrest include surgical procedures and trauma cases. Surgical procedures are medical operations carried out to treat, diagnose, or prevent various conditions, ranging from minor to complex interventions. The product is available in different formulations, such as powder form and pre-mixed solutions, and is distributed through hospitals, pharmacies, and online platforms.
The evarrest market consists of sales of products including the evarrest fibrin sealant patch, surgical powder absorbable hemostat, surgiflo hemostatic matrix, harmonic devices, and endopath products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising cases of oral cancer, increasing prevalence of cancer, increase in chronic conditions, and rising prevalence of chronic and autoimmune diseases. Major trends in the forecast period include advancements in biosimilar development, innovation in drug development, technological advancements in biomarkers and diagnostics, integration of digital technologies, and sustainability in biologics manufacturing.
The growth of the evarrest market is expected to be driven by the increasing number of surgical procedures. Surgical procedures involve medical operations performed by a surgeon to treat, diagnose, or prevent various conditions, injuries, or diseases. The rising number of surgeries is attributed to the aging population and advancements in medical technology, making surgeries safer and more accessible. Evarrest is utilized during surgical procedures by applying its fibrin sealant patch to bleeding sites, where it facilitates rapid clot formation to effectively control bleeding. For example, in December 2023, the UK Health Security Agency reported an increase in coronary artery bypass graft surgeries, with 27,524 surgeries performed in 2023, compared to previous years. As a result, the growing number of surgical procedures is fueling the growth of the evarrest market.
The increasing adoption of personalized medicine is expected to drive the future growth of the evarrest market. Personalized medicine involves treatments tailored to an individual’s genetic makeup, lifestyle, and specific health conditions, aiming to provide more effective and precise care. The rise of personalized medicine is attributed to its ability to offer targeted treatments with fewer side effects. In the case of evarrest, its use can be customized based on patient factors, such as genetic traits or clotting disorders, to enhance treatment efficacy and safety. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from the 6 treatments approved in 2022. Therefore, the growing adoption of personalized medicine is contributing to the expansion of the evarrest market.
The increasing healthcare expenditure is also expected to boost the growth of the evarrest market. Healthcare expenditure encompasses the total financial resources allocated to medical services, preventive care, medications, and health-related activities aimed at improving or maintaining population health. The growth in healthcare spending is driven by the needs of aging populations requiring more medical care and the rising costs of advanced technologies. This increased expenditure supports the adoption of evarrest by investing in medical technologies that improve surgical outcomes and reduce complications. For example, the Centers for Medicare & Medicaid Services reported that U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion, surpassing the 3.2% growth seen in 2021. As a result, rising healthcare expenditure is driving the growth of the evarrest market.
The key company operating in the evarrest market is Johnson & Johnson
North America was the largest region in the evarrest market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in evarrest report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.The countries covered in the evarrest market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Evarrest is an FDA-approved fibrin sealant patch designed to control bleeding during surgical procedures. It consists of a flexible composite patch coated with human fibrinogen and thrombin, which allows for rapid clot formation. This product is particularly valuable in emergency situations, as it requires no preparation and effectively stops bleeding on the first application.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for evarrest include surgical procedures and trauma cases. Surgical procedures are medical operations carried out to treat, diagnose, or prevent various conditions, ranging from minor to complex interventions. The product is available in different formulations, such as powder form and pre-mixed solutions, and is distributed through hospitals, pharmacies, and online platforms.
The evarrest market consists of sales of products including the evarrest fibrin sealant patch, surgical powder absorbable hemostat, surgiflo hemostatic matrix, harmonic devices, and endopath products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Evarrest Market Characteristics4. Evarrest Market Trends And Strategies5. Evarrest Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market7. Global Evarrest Pricing Analysis & Forecasts30. Global Evarrest Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Evarrest Market32. Recent Developments In The Evarrest Market
3. Evarrest Market Biologic Drug Characteristics
6. Global Evarrest Growth Analysis And Strategic Analysis Framework
8. Evarrest Market Segmentation
9. Global Evarrest Epidemiology Of Clinical Indications
10. Evarrest Market Regional And Country Analysis
11. Asia-Pacific Evarrest Market
12. China Evarrest Market
13. India Evarrest Market
14. Japan Evarrest Market
15. Australia Evarrest Market
16. South Korea Evarrest Market
17. Western Europe Evarrest Market
18. UK Evarrest Market
19. Germany Evarrest Market
20. France Evarrest Market
21. Eastern Europe Evarrest Market
22. North America Evarrest Market
23. USA Evarrest Market
24. Canada Evarrest Market
25. South America Evarrest Market
26. Middle East Evarrest Market
27. Africa Evarrest Market
28. Evarrest Market Competitive Landscape And Company Profiles
29. Global Evarrest Market Pipeline Analysis
33. Evarrest Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Evarrest Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on evarrest market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for evarrest ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The evarrest market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: Surgical Procedures; Trauma Cases2) By Formulation: Powder Form; Pre-Mixed Solution
3) By Distribution Channel: Hospitals; Pharmacies; Online Platforms
Key Companies Profiled: Johnson & Johnson
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Johnson & Johnson
